based on 29 analysts
79.31%
Buy
10.34%
Hold
10.34%
Sell
Based on 29 analysts offering long term price targets for Apollo Hospitals Enterprise Ltd. An average target of ₹7877.45
Source: S&P Global Market Intelligence
Apollo Hospitals Enterprise Ltd price forecast by 29 analysts
Upside of17.80%
High
₹8702
Target
₹7877.45
Low
₹5700
Apollo Hospitals Enterprise Ltd target price ₹7877.45, a slight upside of 17.8% compared to current price of ₹6742.5. According to 29 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Apollo Hospitals Enterprise Ltd revenue growth forecast
Expected growth rate Q1, FY2026:38.63%
Forecast
Actual
Including amortisation and stock based compensations
Apollo Hospitals Enterprise Ltd EPS growth forecast
EPS estimate Q1, FY2026:120.39%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.29 % |
3 Month Return | -0.97 % |
1 Year Return | + 22.32 % |
Market Stats | |
Previous Close | ₹6,686.90 |
Open | ₹6,623.55 |
Volume | 2.59L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹96,147.36Cr |
P/E Ratio | 81.27 |
PEG Ratio | 2.41 |
Market Cap | ₹96,147.36 Cr |
P/B Ratio | 11.85 |
EPS | 63.77 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 13.81 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹96,147.36 Cr | 71.89% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
BUY | ₹96,999.34 Cr | 158.58% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
BUY | ₹49,661.15 Cr | 73.9% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
BUY | ₹25,790.33 Cr | 64.12% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
BUY | ₹22,695.88 Cr | 36.89% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Organisation | Apollo Hospitals Enterprise Ltd |
Headquarters | Chennai |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Ltd reported a 63% YoY increase in net profit to ₹379 crore for Q2 FY2024, with revenues rising 15% to ₹5,589 crore. EBITDA also grew by 30% to ₹816 crore, reflecting the company's commitment to expanding healthcare access across India.
Apollo Hospitals Faces Revenue Challenges, Yet Maintains Growth Outlook - 11 Nov, 2024
Apollo Hospitals Enterprise faces a 15% decline in international patient revenue but reports a recovery in net profit. The company maintains a positive growth outlook with a revised target price of Rs 8,000/share, despite competition in the quick commerce space affecting its delivery services.
Apollo Hospitals Reports Strong Q2 Performance - 08 Nov, 2024
Apollo Hospitals Enterprise Ltd. reported a 14.41% increase in net sales for September 2024, with net profit up 25.37%. Analysts raise earnings estimates and set a target price of Rs 8,660, indicating strong growth potential.
Apollo Hospitals Reports Strong Q2 Earnings and Expansion Plans - 07 Nov, 2024
Apollo Hospitals shares surged after reporting a 63% YoY increase in Q2 net profit. The company announced a Rs 1,700 crore capex drive and saw a 59% profit surge, leading to a 6% rise in share price to a one-year high.
Apollo Hospitals Q2 Profit Surges Exceeding Estimates - 06 Nov, 2024
Apollo Hospitals Enterprise Ltd reported a 59% increase in Q2 net profit to ₹395.7 crore, driven by strong revenue growth of 15% to ₹5,589 crore, outperforming market estimates.
Morgan Stanley Upgrades Apollo Hospitals with Target Price - 05 Nov, 2024
Morgan Stanley has given an 'Overweight' rating to Apollo Hospitals, setting a target price of ₹7,110 per share. The company is expanding its capacity with a new 500-bed hospital in Worli, Mumbai, and plans to increase its total bed count by 2,877 over the next few years, indicating strong growth potential.
Apollo Hospitals Plans Expansion and Strong Q2 Earnings - 04 Nov, 2024
Apollo Hospitals is set to establish a 500-bed hospital in Worli, Mumbai, while also anticipating a 55% increase in Q2 profits due to improved operations and digital healthcare performance.
Apollo Hospitals Plans Major Expansion with New Beds - 02 Nov, 2024
Apollo Hospitals Enterprise Ltd. plans to invest ₹6,100 crore to add 3,512 beds across 11 locations in India over four years, enhancing healthcare access.
Apollo Hospitals Partners with IIT for Affordable Healthcare - 21 Oct, 2024
Apollo Hospitals has signed an agreement with IIT Chennai to re-engineer medical devices at significantly reduced costs, aiming to make healthcare solutions more affordable for a broader population.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 11 quarters, 3.58K Cr → 5.63K Cr (in ₹), with an average increase of 4.4% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 43.92% to 45.37% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 7 quarters, 144.5 Cr → 378.8 Cr (in ₹), with an average increase of 14.4% per quarter
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 191.3% return, outperforming this stock by 167.9%
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 76.6% return, outperforming this stock by 54.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 29.33% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, APOLLOHOSP stock has moved down by -2.5%
Retail Holding Down
Retail Investor have decreased holdings from 5.38% to 5.12% in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 14.71% to 12.80% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 29.33% | 0.00 | |
Foreign Institutions | 45.37% | 3.30 | |
Mutual Funds | 12.8% | ||
Retail Investors | 5.12% | ||
Others | 7.38% | 10.84 |
Apollo Hospitals Enterprise Ltd in the last 5 years
Lowest (33.30x)
April 1, 2020
Today (81.27x)
November 19, 2024
Industry (96.41x)
November 19, 2024
Highest (341.36x)
June 29, 2021
Apollo Hospitals Enterprise Ltd’s net profit jumped 62.64% since last year same period to ₹378.80Cr in the Q2 2024-2025. On a quarterly growth basis, Apollo Hospitals Enterprise Ltd has generated 24.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Apollo Hospitals Enterprise Ltd has declared dividend of ₹10 - translating a dividend yield of 0.37%.
Read More about DividendsBearish
Neutral
Bullish
Apollo Hospitals Enterprise Ltd is currently in a Bearish trading position according to technical analysis indicators.
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) share price today is ₹6742.5
Apollo Hospitals Enterprise Ltd is listed on NSE
Apollo Hospitals Enterprise Ltd is listed on BSE
PE Ratio of Apollo Hospitals Enterprise Ltd is 81.27
PE ratio = Apollo Hospitals Enterprise Ltd Market price per share / Apollo Hospitals Enterprise Ltd Earnings per share
Today’s traded volume of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is 2.59L.
Today’s market capitalisation of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is ₹96147.36Cr.
Apollo Hospitals Enterprise Ltd(APOLLOHOSP | Price |
---|---|
52 Week High | ₹7545 |
52 Week Low | ₹5284.85 |
Apollo Hospitals Enterprise Ltd(APOLLOHOSP) share price is ₹6742.5. It is down -10.64% from its 52 Week High price of ₹7545
Apollo Hospitals Enterprise Ltd(APOLLOHOSP) share price is ₹6742.5. It is up 27.58% from its 52 Week Low price of ₹5284.85
Apollo Hospitals Enterprise Ltd(APOLLOHOSP | Returns |
---|---|
1 Day Returns | 55.6% |
1 Month Returns | -4.29% |
3 Month Returns | -0.97% |
1 Year Returns | 22.32% |